Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02101853
Title Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

acute lymphoblastic leukemia

Therapies

Blinatumomab

Leucovorin + Pegaspargase + Vincristine Sulfate

Mercaptopurine + Thioguanine

Asparaginase + Cyclophosphamide + Etoposide

Cytarabine + Dexamethasone + Methotrexate

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.